Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Martha Lassiter

2012 Tata Memorial Hospital Bone Marrow Transplant Program in Kolkata, India

Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Arash Ash Alizadeh

Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Xin Wei Wang

Molecular signatures for Liver cancer diagnosis and treatment stratification

Liver and intrahepatic bile ducts

Pathology

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung Pancreas Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Breast

Laura Pasqualucci

Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma